Our clinical outcomes unveil that miR-27a-3p might exert a carcinogenic effect on the development of IH, while PPAR-γ has a tumor suppressive effect, and the two may have antagonistic effects on the proliferation and regression stages of IH. This evidence concerns the gene PPARG and isolated hemihyperplasia.